iifl-logo
  • testing
  • |

iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Granules bags coveted -Fastest Emerging Company from India†Award

25 Sep 2009 , 06:45 PM

Granules India Limited, a fully integrated pharmaceutical manufacturer headquartered in Hyderabad, bagged the “Fastest Emerging Company from India” Award in the APIs & Intermediaries category at the inaugural Indo-Africa Pharma Business Meet hosted by Pharmexcil. The award ceremony was held today at the Hyderabad Marriott Hotel & Convention Centre.

The event was inaugurated by Chief Guest Anand Sharma, Honourable Minister for Commerce & Industry. Also present at the event were Shri K. Rosaiah, the Chief Minister of Andhra Pradesh, Shri Ashok Kumar Secretary Department of Pharmaceuticals, Dr. Surinder Singh Drug Controller General of India and along with several State Drug Controller.

The Company’s annualized net sales for fiscal year 2008-2009 was Rs. 385.7 Cr., an increase of 50.4% over the prior year. Granules, which has been heavily investing in its business model over the last three years, attributed revenue growth to increased API capacity utilization as well as the introduction and commercialization of its finished dosage business. Granules serve over 300 customers in 50 countries through sales offices in India, U.S., U.K. China and Colombia.

“We are excited to be recognized by Pharmexcil because this award acknowledges the robustness of our business model. Our integrated value chain allows us to deliver high-quality, high-volume products to customers throughout the world. There are very few pharmaceutical companies that can handle our volume level. To give you an example of our scale, every minute across the globe, 60,000 tablets are consumed using materials produced by Granules. Going forward, we anticipate sustaining the same growth levels.” says Mr. Harsha Chigurupati, Chief Marketing Officer at Granules after receiving the award from Shri Ashok Kumar, Secretary Department of Pharmaceuticals.                 

sidebar mobile

BLOGS AND PERSONAL FINANCE

Images

Demo for economy

Whatsapp
Facebook
Twitter
LinkedIn
6 Mar 2024|03:40 PM
Images
4 Mar 2024|04:16 PM
Read More

Most Read News

Testing Long Posts
12 Aug 2024|10:15 AM
Stocks under F&O ban on August 07, 2024
7 Aug 2024|01:38 PM
Testing video in article
13 May 2024|01:15 PM
Testing font sizes
14 Mar 2024|10:30 AM
Testing for Category
11 Mar 2024|02:23 PM
Read More
testing
  • testing
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

testing
  • testing
  • testing

ATTENTION INVESTOR

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.